Clinical Trial Update: Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. [Phase 2]

View source ↗

Summary

Phase II comparator trial evaluating substitution of Tenofovir or Abacavir within HAART for HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)
• Ziagen (Abacavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV | Phase 2 | Status: COMPLETED